Cargando…
Reply to Helgeson et al.: Remote 6-minute-Walk Testing in Patients with Pulmonary Hypertension: Further Validation Needed?
Autores principales: | LaPatra, Tess, Baird, Grayson L., Goodman, Randi, Pinder, Diane, Gaffney, Maeve, Klinger, James R., Palevsky, Harold I., Fritz, Jason, Mullin, Christopher J., Mazurek, Jeremy A., Kawut, Steven M., Ventetuolo, Corey E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Thoracic Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716915/ https://www.ncbi.nlm.nih.gov/pubmed/35608538 http://dx.doi.org/10.1164/rccm.202205-0867LE |
Ejemplares similares
-
“It's that invisible illness”: Patient and clinician perspectives on outcomes in pulmonary arterial hypertension treatment
por: Auriemma, Catherine L., et al.
Publicado: (2023) -
Systemic arterial properties in pulmonary hypertension
por: Goodman, Randi, et al.
Publicado: (2021) -
The Modified Borg Dyspnea Scale does not predict hospitalization in pulmonary arterial hypertension
por: Banerjee, Debasree, et al.
Publicado: (2017) -
Experimental design of the Effects of Dehydroepiandrosterone in Pulmonary Hypertension (EDIPHY) trial
por: Walsh, Thomas P., et al.
Publicado: (2021) -
Symptom phenotypes in pulmonary arterial hypertension: The PAH “symptome”
por: Matura, Lea Ann, et al.
Publicado: (2022)